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Staphylococcus aureus may cause serious skin and soft tissue infections, deep abscesses,
endocarditis, osteomyelitis, pneumonia, and sepsis. S. aureus persistently colonizes 25–
30% of the adult human population, and S. aureus carriers have an increased risk for
infections caused by the bacterium. The major site of colonization is the nose, i.e., the
vestibulum nasi, which is covered with ordinary skin and hair follicles. Several host and
microbe determinants are assumed to be associated with colonization. These include the
presence and expression level of bacterial adhesins, which can adhere to various proteins in
the extracellular matrix or on the cellular surface of human skin.The host expresses several
antimicrobial peptides and lipids. The level of β-defensin 3, free sphingosine, and cis-6-
hexadecenoic acid are found to be associated with nasal carriage of S. aureus. Other host
factors are certain polymorphisms inToll-like receptor 2, mannose-binding lectin, C-reactive
protein, glucocorticoid-, and vitamin D receptor. Additional putative determinants for car-
riage include genetic variation and expression of microbial surface components recognizing
adhesive matrix molecules and their interaction partners, as well as variation among
humans in the ability of recognizing and responding appropriately to the bacteria. Moreover,
the available microﬂora may inﬂuence the success of S. aureus colonization. In conclusion,
colonization is a complex interplay between the bacteria and its host. Several bacterial
and host factors are involved, and an increased molecular understanding of these are
needed.
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INTRODUCTION
Human skin is easily accessible for microbial colonization and
provides a wide variety of environmental conditions for growth.
One of our most potent pathogens, Staphylococcus aureus, is a
ubiquitous commensal that persistently colonizes 25–30% of the
human population (Wertheim et al., 2004; van Belkum, 2011).
S. aureus is the major cause of skin and soft tissue infections, and
the bacteria can also infect any tissue of the body, causing other
serious or life-threatening diseases, such as deep abscesses, endo-
carditis, osteomyelitis, and pneumonia. S. aureus is one of the
most prevalent pathogens in bloodstream infections and effective
treatment is a major clinical challenge. Emergence and spread
of antimicrobial resistance combined with increasing numbers
of immune-compromised patients make infections increasingly
difﬁcult to treat (Tong et al., 2012). Infection rates are higher
in carriers of S. aureus than in non-carriers and invasive dis-
ease is often caused by the strain carried by the patient (von Eiff
et al., 2001a; Wertheim et al., 2004). Eradication of nasal coloniza-
tion with antibiotic treatment decreases the risk of post-operative
infections (van Rijen et al., 2008), which may support an approach
inwhich systemic S. aureus infections are prevented by eliminating
or reducing nasal carriage.
Historically, individuals have been classiﬁed as non-carriers,
intermittent carriers, or persistent carriers of S. aureus. How-
ever, non-carriers and intermittent carriers share similar nasal
elimination kinetics and anti-staphylococcal antibody proﬁles.
Therefore, a reclassiﬁcation of S. aureus nasal carriage is suggested
and includes only two types of nasal carriers: persistent or oth-
ers (van Belkum et al., 2009). The persistent carriage rate varies
depending on age, gender, serum glucose level, smoking, oral con-
traceptive use, dialysis, and/or drug addiction (Kluytmans et al.,
1997; Choi et al., 2006; Olsen et al., 2009; van Belkum, 2011). Vari-
ous diseases are also associatedwith increased carriage rate, such as
Wegener’s granulomatosis patientswith 63–72%, atopic dermatitis
(AD) patients with almost 100% and rheumatoid arthritis patients
with 50% carriage rate (Breuer et al., 2002; Laudien et al., 2010).
Still, the success of S. aureus to colonize human nares remains an
enigma. Since not all humans are persistent carriers and some bac-
terial clones are more common than others within a population,
both human and microbial determinants seem to be involved. In
this paper, we intend to review and discuss various parameters that
may contribute to nasal carriage.
STAPHYLOCOCCUS AUREUS COLONIZATION OF THE
HUMAN HOST
LOCALIZATION OF S. AUREUS
Staphylococcus aureus has been found in human nose, throat, per-
ineum, and intestine (Wertheim et al., 2005; Mertz et al., 2007;
Acton et al., 2009). However, as decolonization of the nose usually
has a decolonizing effect on perineum, pharynx, and axillae as
well, the nose is assumed to be the major site of S. aureus coloniza-
tion (Kluytmans and Wertheim, 2005) although sole intestinal
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carriage also can occur (Acton et al., 2009). Sampling of the
various areas inside the noses of healthy individuals revealed
that S. aureus is mainly localized in the vestibulum nasi (Cole
et al., 2001), and the bacterial load of two persistent carriers var-
ied between 104 and 105 bacteria/nasal swab over time (Burian
et al., 2010b).
Intracellular S. aureus have been found in biopsies from the
anterior part of the middle turbinate or tonsils from patients
with recurrent rhinosinusitis or tonsillitis, respectively (Clement
et al., 2005; Zautner et al., 2010). The intracellular residency in
epithelial cells was a signiﬁcant risk factor for recurrent episodes
of rhinosinusitis (Plouin-Gaudon et al., 2006). The intracellular
localization of S. aureus is thought to be part of the patho-
physiological mechanisms behind prolonged course, chronic, or
frequent relapse of rhinosinusitis, osteomyelitis, mastitis, or endo-
carditis (Plouin-Gaudon et al., 2006; Garzoni and Kelley, 2009;
Sinha and Fraunholz, 2010). S. aureus can be internalized by
various cell types, such as endothelial cells, epithelial cells, ﬁbrob-
lasts, osteoblasts, and keratinocytes in addition to the professional
phagocytes (Garzoni and Kelley, 2009). The invasiveness and sur-
vival of bacteria within the mammalian cells varies, and may
depend on bacterial strain, ability to form small colony variant
(SCV), multiplicity of infection (MOI) as well as the mammalian
cell type. Prolonged survival of bacterial cells can result in release
of viable bacterial cells when the host cell dies (von Eiff et al.,
2001b; Krut et al., 2003; Garzoni and Kelley, 2009; Sinha and
Fraunholz, 2010). Whether S. aureus can be found intracellular
within keratinocytes during nasal colonization remains unknown,
but S. aureus is rapidly invading the keratinocytes in skin biopsies
taken from human hosts (Kisich et al., 2007).
FEATURES OF THE COLONIZED TISSUE
A histological study of human cadavers revealed bacteria in strat-
iﬁed squamous epithelium and hair follicle shafts in the nose
(Ten Broeke-Smits et al., 2010). The outermost area in the nose
is covered by ordinary skin, which is divided into two main
structures: a layer of highly regenerating epidermis and dermis,
which is drained by lymphatic and vascular conduits (Nestle
et al., 2009). The dominating cell type in epidermis is ker-
atinocytes, but also Langerhans cells, melanocytes, Merkel cells,
and T cells are present (Nestle et al., 2009; Hari et al., 2010).
The keratinocytes in the basal layer (stratum basale) express the
basal keratins K5, K14, and K15. Through continuous prolifera-
tion, the basal layer provides cells that differentiate, move, and
form the stratum spinosum. The postmitotic cells in stratum
spinosum express suprabasal keratins K1 and K10, which rein-
force mechanical strength of the layer. These cells continue to
differentiate and form stratum granulosum. The keratinocytes in
stratum granulosum contain lamellar bodies, which are secre-
tory organelles that are unique to epidermis. In the terminal
differentiation of keratinocytes, ﬁlaggrin aggregates the keratin
ﬁlaments into tight bundles, promoting the collapse of the cells.
The resulting multilayer of ﬂattened, anucleated corneocytes is
called stratum corneum or the corniﬁed layer. Corneocytes con-
tain a corniﬁed envelope consisting of structural proteins such as
involucrin, loricrin, trichohyalin, transglutaminases, and ﬁlag-
grin in addition to keratin K1 and K10 providing mechanical
strength. A complex series of lipids are covalently attached to the
proteins of the corniﬁed envelope. Moreover, the laminar bodies
secrete hydrolytic enzymes as well as phospholipids, ceramides,
glycosyl ceramides, and sterols, which can be further metabo-
lized in the extracellular space (Proksch et al., 2008; Nestle et al.,
2009). Additional lipids are provided by the sebaceous glands
(Toth et al., 2011).
Almost all patientswithADare colonizedwith S. aureus (Breuer
et al., 2002). Loss-of-function variants of the structural epider-
mal protein ﬁlaggrin are present in 9% of European population
and are found to be predisposing factor for AD (Palmer et al.,
2006). Individuals with loss-of-function ﬁlaggrin have signiﬁ-
cantly reduced natural moisturizing factor in stratum corneum
and higher transepidermal water loss (Kezic et al., 2008). The
components of natural moisturizing factor include urocanic acid
(UCA) and pyrrolidone carboxylic acid (PCA), which in addition
to hydration may also be involved in pH regulation of the skin.
UCA and PCA are breakdown products from ﬁlaggrin. Physiolog-
ical concentrations of these compounds reduce the growth rate of
S. aureus as well as the expression of bacterial proteins involved in
colonization and immune evasion. This suggests that colonization
of individuals with loss-of-function mutations of ﬁlaggrin, which
lacks the breakdown products in skin, may have a reduced ability
to inhibit S. aureus growth (Miajlovic et al., 2010).
BACTERIAL AND HOST PROTEINS INVOLVED IN ADHESION
The adherence between S. aureus and the nasal epithelium is a
multifactorial process that involves various interaction partners
in both organisms. The primary bacterial adherence is thought
to be mediated by wall teichoic acid (WTA), whereas sortase-
anchored microbial surface components recognizing adhesive
matrix molecules (MSCRAMMs) have critical roles at later stages
of colonization of the human nose (Weidenmaier et al., 2008;
Burian et al., 2010a). Detailed MSCRAMM-host interaction in
vitro studies have revealed that S. aureus clumping factor B (ClfB)
adheres to cytokeratin K10 (O’Brien et al., 2002; Wertheim et al.,
2008; Clarke et al., 2009) and K8 (Haim et al., 2010). ClfB is
expressed during nasal colonization and contributes to nasal col-
onization in humans (Wertheim et al., 2008; Burian et al., 2010b).
However, ClfB-deﬁcient cells of S. aureus strains 8325-4 and New-
man could still interact with the nasal cells (O’Brien et al., 2002),
which clearly demonstrate the utilization of several independent
MSCRAMMs for colonization.
Another S. aureus adhesin that has shown interactions with
harvested human desquamated epithelial cells is Iron-regulated
surface determinant A (IsdA) (Clarke et al., 2006), which is also
expressed during nasal colonization in humans (Burian et al.,
2010b). The corneocyte envelope proteins loricrin and involucrin
are identiﬁed as IsdA interaction partners (Clarke et al., 2009).
The bacterial proteins SdrC, SdrD, and SasG are also shown to
promote adhesion of bacteria to desquamated nasal epithelial cells
harvested from human donors (Roche et al., 2003; Corrigan et al.,
2009). Several other S. aureus MSCRAMMs or adhesins are identi-
ﬁed,which interact with hostmolecules such as ﬁbrinogen, elastin,
collagen, or von Willebrand factor (Heilmann, 2011). However,
the involvement of these factors in nasal colonization remains
elusive.
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The panel of MSCRAMMs varies among S. aureus isolates
(McCarthy and Lindsay, 2010). Interestingly, comparison of S.
aureus 8325-4 and S. aureus 8325-4 (pKS80::sasG) showed that
expression of SasG reduced S. aureus adherence to ﬁbrinogen and
ﬁbronectin. Thus, certain MSCRAMMs might mask the adhe-
sive functions of other adhesins, and possibly even change the
tropism for the host cell (Roche et al., 2003). The individual
combinations of MSCRAMMs may therefore inﬂuence the micro-
bial success of adhesion. Also, allelic variations between bacterial
adhesins of the same type may also either improve or reduce their
binding to human cells. Moreover, there may be variations in
expression level of MSCRAMMs. Different MSCRAMM expres-
sion proﬁles were, for example, observed for so-called carrier and
non-carrier strains of S. aureus, where the carrier strain expressed
a markedly larger number of adhesive proteins such as SasD and
SdrH (Muthukrishnan et al., 2011).
Cells from different donors provide variable levels of adhe-
sion to S. aureus (Aly et al., 1977; Weidenmaier et al., 2008). This
may suggest that there are differences in the expression levels
or different polymorphic variants of human interaction partner,
which may inﬂuence the level of bacterial adhesion. Fibronectin
and ﬁbrinogen contribute to S. aureus binding. Fibronectin
has been found in stratum corneum of AD skin, but not in
healthy skin, which may partly explain the abundant coloniza-
tion of atopic skin (Cho et al., 2001). Also, AD patients have an
impaired proliferation and differentiation in both non-lesional
and lesional skin, as seen by immunohistochemistry of Ki67 (a
marker of cell proliferation; Scholzen and Gerdes, 2000), involu-
crin, loricrin, ﬁlaggrin, and the keratins K5, K6, K10, K16,
and K17 (Jensen et al., 2004). Loricrin, involucrin, and K10 are
interaction partners for ClfB and/or IsdA, and aberrant distri-
bution of the interaction partners of these may be beneﬁcial
for colonization. Finally, there has also been found amino acid
variation in elastin, ﬁbrinogen/ﬁbrin, ﬁbronectin, prothrombin,
vitronectin, and von Willebrand factor (McCarthy and Lindsay,
2010). Such an amino acid variation may also inﬂuence the risk of
colonization.
All these studies suggest that the success of adhesion to host
may depend on the correct combination and allelic variant of
MSCRAMM together with the appropriate expression and variant
of human host ligand.
EXPRESSION OF COLONIZATION DETERMINANTS
Burian et al. (2010b) addressed the expression of several S. aureus
transcripts duringnasal colonizationof humans. Thebacteriawere
found to express the adhesive molecules (clf B, isdA, fnbA, atlA,
eap, WTA), genes involved in cell surface dynamics/remodeling
(sceD, oatA, atlA) and immune-modulatory factors (sak, chp,
spa, eap) under these conditions. In contrast, the major tox-
ins (hla, psm) were not transcribed during colonization of the
human nose.
The environment in the nose may also require reactive oxygen
species and desiccation tolerance. Alkyl hydroperoxide reductase
(AhpC) and catalase (katA), which engender increased H2O2 tol-
erance, were found to be associated with nasal carriage in a cotton
rat model (Cosgrove et al., 2007), but their possible impact on
colonization of the human nose is not known.
INFLUENCE OF BIOFILM
Bioﬁlm and planktonic cultures of S. aureus have different impacts
on gene expression in keratinocytes (Secor et al., 2011). In nasal
secretion, a so-called carrier strain of S. aureus, but not a non-
carrier strain, was surrounded by an additional electron-dense
layer covering the peptidoglycan, which might represent the ini-
tial stages of bioﬁlm formation (Cole et al., 2001; Quinn et al.,
2009). This may provide resistance against phagocytosis and/or
oxidative burst. Moreover, the carrier strain bioﬁlm exoproteome
contained a greater number of immunoevasive proteins than
its planktonic counterpart (Muthukrishnan et al., 2011). How-
ever, a dispersed rather than bioﬁlm-related mode of growth is
thought to occur during S. aureus nasal colonization (Krismer
and Peschel, 2011).
THE INFLUENCE OF MICROFLORA ON S. AUREUS NASAL CARRIAGE
The nares are colonized by a temporally stable microbiota dis-
tinct from other regions of the integument (Frank et al., 2010).
The nasal microbiota of healthy adults has been shown to consist
primarily of members of the phylum Actinobacteria (e.g., Propi-
onibacterium spp. and Corynebacterium spp.), but also Firmicutes
(e.g., Staphylococcus spp.) and Proteobacteria (e.g., Enterobac-
ter spp.) (Frank et al., 2010; Wos-Oxley et al., 2010). Healthy
adults harbor signiﬁcantly more species-rich and diverse nares
microbiotas thanhospitalized individuals (Wos-Oxley et al., 2010).
Staphylococcus epidermidis is the most commonly isolated bac-
terial species from healthy human skin and may protect humans
from pathogenic bacteria. S. epidermidis produce phenol-soluble
modulins, which inhibit the growth of Streptococcus pyogenes.
These modulins also induce lipid vesicle leakage and exert antimi-
crobial action against S. aureus (Cogen et al., 2010a,b). In addition,
Lai et al. (2009) showed that the microﬂora can modulate speciﬁc
cutaneous inﬂammatory responses and that a product of staphylo-
cocci, lipoteichoic acid (LTA), inhibits skin inﬂammation. More-
over, S. epidermidis LTA modulates the inﬂammation through a
Toll-like receptor (TLR)-cross-talk phenomenon between TLR2
and TLR3. Finally, the presence of S. epidermidis has been shown
to induce expression of human β-defensin 2 (hBD2) andhuman β-
defensin 3 (hBD3) in keratinocytes, thereby inhibiting the growth
of pathogenic organisms, e.g., S. aureus and group A streptococci
(GAS) (Lai et al., 2010).
Staphylococcus aureus carriage has been shown to be nega-
tively associated with a variety of other nares-associated microbial
species, most signiﬁcantly S. epidermidis and Propionibacterium
acne (Frank et al., 2010). Bogaert et al. (2004) noted a nega-
tive correlation for co-colonization of S. aureus and vaccine-type
pneumococci in the nasopharynx of children, but not for S.
aureus and non-vaccine serotype pneumococci, suggesting that
there might be a natural competition between colonization with
vaccine-type pneumococci and S. aureus.
Uehara et al. (2000) reported a low incidence of S. aureus
carriage in individuals who also were positive for Corynebac-
terium sp. by nose swabs suggesting competition for survival
between S. aureus and corynebacteria. Lina et al. (2003) later
showed that the S. aureus nasal colonization rate correlated neg-
atively with the rate of colonization by Corynebacterium spp. and
S. epidermidis, suggesting that both Corynebacterium spp. and
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S. epidermidis antagonize S. aureus colonization. Colonization by
methicillin-resistant S. aureus (MRSA) agr-1Sa strains was specif-
ically associated with a low rate of colonization by Corynebac-
terium spp. and agr-3Se S. epidermidis (Lina et al., 2003), thus
suggesting a potential competitive interaction among different
species with special emphasis on the inﬂuence of staphylococcal
agr alleles.
Staphylococcus epidermidis may also “protect” the host from
S. aureus colonization via quorum sensing cross-inhibition. Pro-
duction of speciﬁc peptide pheromones affect agr signaling in
competing bacteria, and thus lead to colonization inhibition
of, e.g., S. aureus (Otto et al., 2001). A serine protease (Esp,
27 kDa) secreted by a subset of S. epidermidis can inhibit S. aureus
bioﬁlm formation and nasal colonization in vivo. S. epidermidis
cells were introduced into the nasal cavities of volunteers who
were S. aureus carriers. The wild-type S. epidermidis eliminated
S. aureus colonization, but its isogenic esp mutant did not (Iwase
et al., 2010).
The displacement of S. aureus by S. pneumoniae in the
nasopharynx may be explained by H2O2-mediated bacterial inter-
ference. Hydrogen peroxide produced by S. pneumoniae kills
lysogenic but not non-lysogenic staphylococci by inducing the
SOS response. The SOS response induces resident prophages
and thereby lysis and H2O2 lethality (Selva et al., 2009). It has
also been shown that production of H2O2 by viridans group
streptococci may inhibit MRSA colonization of oral cavities in
newborns (Uehara et al., 2001). But in mixed-inoculum coloniza-
tion experiments and experiments where S. aureus invaded the
nasopharynx of rats with established S. pneumoniae populations,
the density of S. aureus did not differ whether the S. pneumo-
niae strain was H2O2 secreting or non-H2O2 secreting (Margolis
et al., 2010).
HOST MOLECULES THAT MIGHT INFLUENCE
S. AUREUS CARRIAGE
Staphylococcus aureus colonizes thehumannares in an area covered
with ordinary skin supplemented with nasal secretions. Thus, host
molecules thatmight inﬂuence S. aureus carriage should be consti-
tutively expressed and/or induced in the skin or nasal secretions. In
the following, the focuswill be on antimicrobialmolecules, various
cytokines, and the signaling pathways involved in the induction of
them. In addition, we will provide examples of known polymor-
phisms in the signal molecules and complement factors/regulators
that may inﬂuence the host defense against colonization or infec-
tion against S. aureus. Therewill also be abrief discussion about the
adaptive immune system and its contribution to host protection
against S. aureus colonization.
ANTIMICROBIAL MOLECULES AND COLONIZATION
The epidermis contains several antimicrobial lipids, peptides, or
proteins provided by keratinocytes, sebocytes, mast cells, and
eccrine sweat glands and also by circulating neutrophils or nat-
ural killer cells that are recruited to the skin (Schauber and Gallo,
2009). The various antimicrobial molecules may act in synergy to
prevent colonization (Proksch et al., 2008), and their individual
or combined expression pattern may inﬂuence the colonization
status of S. aureus.
Lipids
Lipids in epidermis that have antimicrobial activity against
S. aureus are the fatty acids lauric acid, sapienic acid, oleic
acid, palmitoleic acid, and cis-6-hexadecenoic acid (Wille and
Kydonieus, 2003; Takigawa et al., 2005; Nakatsuji et al., 2009; Chen
et al., 2011; Toth et al., 2011). Similarly, sphingoid bases are synthe-
sized from ceramides, and have broad antibacterial and antifungal
activities (Proksch et al., 2008). A reduction in free sphingosine
and cis-6-hexadecenoic acid has been found to be associated with
carriage of S. aureus amongADpatients (Arikawa et al., 2002; Taki-
gawa et al., 2005). However, whether this pattern is found among
healthy carriers is unknown.
Antimicrobial peptides/proteins
Another important player in the ﬁrst-line defense in skin are
antimicrobial peptides (AMPs) or proteins (Yamasaki and Gallo,
2008; Wiesner and Vilcinskas, 2010). Production of AMPs may
be constitutive or induced by inﬂammation or injury. The various
tissues produce speciﬁc proﬁles of differentAMPs, whichmay vary
signiﬁcantly depending on the physiological condition. AMPshave
the ability to kill the pathogens directly, and also to initiate a host
defense response by signaling via receptors resulting in produc-
tion of chemokines and recruitment of immune cells (Yamasaki
and Gallo, 2008; Wiesner and Vilcinskas, 2010). In the follow-
ing, we intend to provide a few examples of AMPs and proteins,
and describe what is known regarding them and colonization with
S. aureus.
Human α-defensins, also called human neutrophil peptides,
include the peptides HNP 1–4 and HD 5–6. The former are
expressed in neutrophils, while the latter two peptides are mainly
expressed in Paneth cells in the small intestine. The human β-
defensins (hBD1–4) are expressed in mucosa and epithelial cells
(Yamasaki and Gallo, 2008; Wiesner and Vilcinskas, 2010). The
β-defensins have been compared in their antimicrobial activity
against S. aureus, and the most potent is β-defensin 3 followed
by β-defensin 2 and β-defensin 1 (Midorikawa et al., 2003; Chen
et al., 2005; Kisich et al., 2007). Keratinocytes have constitutive
capacity to kill S. aureus, a phenomenon that is dependent on
β-defensin 3 (Kisich et al., 2007). Comparisons of skin biopsies
revealed that the levels of β-defensin 3 are similar between normal
individuals and those with AD. However, the AD patients have
a reduced ability to mobilize β-defensin 3 onto the bacteria due
to presence of Th2 cytokines (Kisich et al., 2008). Also, a higher
induction of β-defensin 3, but not β-defensin 2, is associated with
a better clinical course and outcome of S. aureus skin infections
(Zanger et al., 2010). Moreover, the level of both constitutive and
induced β-defensin 3 is lower in persistent S. aureus nasal carriers
compared to non-carriers, suggesting that β-defensin 3 is a deter-
minant for carriage (Zanger et al., 2011). All these studies show
the importance of presence of β-defensin 3 in clearing of S. aureus
in colonization and infection.
The expression level of defensins may be regulated at several
stages. The genes encoding β-defensins are clustered in chromo-
some8p23.1,which is a frequent site of genetic rearrangement, and
copy numbers of defensin genes may therefore vary among indi-
viduals (Linzmeier et al., 1999). However, no associations between
nasal carriage of S. aureus and copy number and/or sequence
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variations among HNP 1–3 or β-defensin 3 have been found (van
Belkum et al., 2007; Fode et al., 2011). Both α- and β-defensins
are secreted as proproteins, and post-translational processing is
needed in order to create mature defensins (Yamasaki and Gallo,
2008). The defensins’ processing enzymes in human skin are
unknown, and whether the activity of these inﬂuence carriage
status is also unknown.
Cathelicidin is another AMP that is important in skin. The
protein is stored as a proprotein named hCAP18 in laminar
bodies in keratinocytes and secreted into the spinous layer of
epidermis, where local proteases process the protein into active
peptide(s). Stratum corneum tryptic enzyme (SCTE) modiﬁes
the propeptide into LL-37 at the skin surface. Then, a combina-
tionof SCTEand stratumcorneumchymotryptic protease (SCCE)
may further process LL-37 into smaller peptides known as RK-31
and KS-30 (Yamasaki and Gallo, 2008). RK-31 and KS-30 have
increased antimicrobial activity against S. aureus compared to LL-
37 (Murakami et al., 2004). Whether the level and/or function of
SCTE/SCCE and/or level of the processed peptides are associated
with nasal carriage is not known.
Vitamin D appears to promote with both innate and adap-
tive immunity. The active variant 1,25-(OH)2-D3 has been found
to enhance the antimicrobial function against S. aureus in vitro
(Schauber et al., 2007, 2008). The promoter of the antimicrobial
proteins cathelicidin and β-defensin 2 have vitamin D responsive
elements (VDREs) (Gombart et al., 2005), and 1,25-(OH)2-D3
can induce cathelicidin and/or β-defensin 2 in isolated human
keratinocytes, monocytes, neutrophils, and myeloid cells as well
as in human skin biopsies (Wang et al., 2004; Gombart et al.,
2005; Weber et al., 2005). Also, supplementation of oral vitamin D
induced cathelicidin production in AD lesional skin (Hata et al.,
2008). In addition to inducing AMP expression, 1,25-(OH)2-D3
has been found to induce CD14 and TLR2 expression in ker-
atinocytes (Schauber et al., 2007), which may result in increased
ability to detect pathogens. Epidemiological studies suggest that
polymorphism in vitamin D responsive genes might be asso-
ciated with S. aureus carriage among type I diabetes patients
(Panierakis et al., 2009), but not among a healthy, elderly popula-
tions (Claassen et al., 2005). There is also reported an association
between vitamin D deﬁciency and MRSA nasal carriage (Mathe-
son et al., 2010). Recently, we found that nasal carriage of S. aureus
is associated with serum 25-hydroxyvitamin D level, gender, and
smoking status (Olsen et al., 2011). All these studies suggest that
the vitamin D protects against carriage of S. aureus, which may be
due to, among other factors, increased expression of cathelicidin
in the skin.
RNase 7 is an additional AMP found in stratum corneum.
Lower RNase 7 expression in healthy skin is associated with
increased risk for new onset of S. aureus skin infection (Zanger
et al., 2009). However, no association was found between RNase 7
level and carriage of S. aureus (Zanger et al., 2011).
Finally, there are several other proteins that may have
antimicrobial activity against S. aureus. Examples include derm-
cidin and histone H4, which are expressed in eccrine sweat
glands and by sebocytes, respectively, and secreted to the
skin (Rieg et al., 2004; Lee et al., 2009). Moreover, secretory
leukocyte protease inhibitor (SLPI) and elaﬁn/elastase-speciﬁc
inhibitor (ESI)/skin-derived antileukoprotease (SKALP) kill S.
aureus (Hiemstra et al., 1996; Simpson et al., 1999), and the pro-
teins can be induced in keratinocytes/epidermis (Bando et al.,
2007). Another class of putative relevant antimicrobial proteins
is the peptidoglycan recognition proteins (PGRPs; Dziarski and
Gupta, 2010). Furthermore, several cytokines and chemokines
are found to have antimicrobial activity against S. aureus to
various degrees: CXCL1/Groα, CXCL2/Groβ, CXCL3/Groγ,
CXCL9/MIG, CXCL10/IP-10, CXCL11/I-TAC, CXCL12/SDF-1,
CXCL13/BCA-1, CXCL-14/BRAK, XCL1/lymphotactin, CCL1/I-
309, CCL11/eotaxin, CCL17/TARC, CCL18/PARC, CCL20/MIP3-
α, CCL21/SLC, CCL22/MDC, CCL25/TECK, IL-1α, and IL-1β
(Yang et al., 2003; Quinn et al., 2009). However whether the com-
bination or expression level of any of the mentioned proteins
inﬂuence carriage is unknown.
Nasal secretion and its effectors
Several proteins have been identiﬁed in nasal secretions, among
them α-defensin 1–2, β-defensin 1–2, lysozyme, lactoferrin, and
hemoglobin (Cole et al., 1999; Pynnonen et al., 2011). Carriers of
S. aureus have elevated levels of α-defensins 1–3, β-defensin 2,
lactoferrin, and slgA in their nasal secretions (Cole et al., 2001;
Kartashova et al., 2009). As α-defensins 1–3 are expressed in
neutrophils, the elevated level may indicate the presence and/or
activation of neutrophils in nasal secretion or epidermis among
carriers. However, this remains to be investigated. The presence of
hemoglobin in nasal secretions was recently found to be another
host determinant for S. aureus colonization. The mechanism may
involve hemoglobin-mediated inhibition of the expression of the
agr quorum sensing system (Pynnonen et al., 2011).
THE HOST IMMUNITY AND S. AUREUS CARRIAGE
Bacteria contain or may secrete substances that are recognized
by the host as pathogen-associated molecular patterns (PAMPs).
The bacterial cell wall of S. aureus is composed of multiple
peptidoglycan layers in combination with WTAs, LTA, and var-
ious MSCRAMMs. Moreover, the bacteria secrete N-formylated
methionine and/or other substances that can be recognized as
PAMPs (Fournier and Philpott, 2005). The cells involved in
the innate immune system express various pattern-recognition
receptors (PRRs), which speciﬁcally recognize PAMPs (Figure 1).
Among the PRRs known to be involved in recognizing S. aureus
is the TLR2 in various combinations with TLR1 or TLR6 and/or
CD36 and CD14 (Fournier and Philpott, 2005; Nilsen et al., 2008)
as well as the intracellular nucleotide-binding and oligomeriza-
tion domain (NOD)-like receptors (NLRs) NOD2 and NLRP3
(Fournier and Philpott, 2005; Craven et al., 2009). Activation of
PRRs activates intracellular signaling resulting in altered gene
expression (Figure 1). In addition, mannose-binding lectin
(MBL) or ﬁcollins may also bind to pathogens, thereby activating
the complement system followed by opsonization and increased
phagocytosis of the bacteria (Casanova and Abel, 2004).
Signaling through TLR
Toll-like receptor is a transmembrane glycoprotein, which consists
of an extracellular domain, a transmembrane domain, and a cyto-
plasmic Toll/interleukin-1 receptor (TIR) domain. Ligand binding
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FIGURE 1 | A simplified overview of how a cell responds to the presence
of S. aureus components. LTA and lipoproteins are recognized as PAMPs by
cellular membrane boundTLRs such asTLR2:TLR1 or TLR2:TLR6. The
activation of TLRs results in recruitment of adaptors (e.g., MyD88) which via
IRAKs activate signal cascades resulting in nuclear translocation of the
transcription factor NFκB. The nuclear localized NFκB stimulates the
transcription of AMPs and cytokines (e.g., IL-1β). Breakdown products from
peptidoglycan (e.g., muramyl dipeptide) and other bacterial proteins (e.g.,
α-hemolysin) are recognized as PAMPs by the intracellular receptors NOD2
and NALP3, respectively. The activation of NALP3 results in the assembly of
the inﬂammasome, resulting in caspase-1 activation, followed by IL-1β
processing and secretion. The activation of NOD2 can result in activation of
NFκB resulting in AMP production, and perhaps also inﬂammasome
assembly. Since little is known about intracellular signaling induced by
MSCRAMMs, they were not included in the ﬁgure even though some of their
interaction partners are known.
to TLRs results in recruitment of other TIR-containing proteins
such as the adaptor protein myeloid differentiation primary-
response protein 88 (MyD88), TIR-domain-containing adaptor
protein (TIRAP), TIPAP-inducing interferon (IFN)-β (TRIF) or
TRIF-related adaptor molecule (TRAM). This initiates a signal-
ing cascade involving IL-1R-associated kinases (IRAKs) and other
kinases, which activates mitogen-activated kinases (MAPKs) and
transcription factors such as nuclear factor κB (NFκB) and IFN-
regulatory factors (IRFs). The ﬁnal result of the activation of the
cascade is increased expression and secretion of various AMPs,
cytokines, and chemokines, thereby recruiting immune cells to the
site of infection and triggering of the adaptive immune response
(Akira and Takeda, 2004; Kumar et al., 2009).
Subcutaneous inoculation of S. aureus into TLR2-, MyD88-,
and IL-1R-deﬁcient mice revealed that IL-1R/MyD88 signaling in
resident skin cells were of particular importance in neutrophil
recruitment to the site of infection (Miller et al., 2006). IL-1R
ligands include IL-1α and IL-1β. Studies in mice showed that
bone marrow cell-derived IL-1β, but not IL-1α, was found to
be important for IL-1R-induced neutrophil recruitment against
cutaneous S. aureus challenge in vivo (Miller et al., 2007). In
humans, treatment of rheumatoid arthritis with IL-1 recep-
tor antagonists results in increased susceptibility to S. aureus
infections (Miller and Cho, 2011), but whether IL-1 receptor
signaling is of importance in protecting against colonization is
not known.
Autosomal recessive MyD88- and IRAK4-deﬁcient humans
have been identiﬁed. The patients have a predisposition to
severe bacterial infections, and S. aureus was the cause of inva-
sive infection in 14 and 20% of IRAK4- and MyD88-deﬁcient
patients, respectively. The patients also had recurrent, localized
skin infections often caused by S. aureus (Picard et al., 2011).
The above-mentioned knock-out studies in mice as well as
the autosomal recessive MyD88 and IRAK-4 patients demonstrate
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that TLR2 and MyD88 are of importance in protecting against
S. aureus. Epidemiological studies show no or little association
between TLR2 R753Q and/or the GT repeat and severe S. aureus
infection (Lorenz et al., 2000; Moore et al., 2004); however, an
association between a TLR2 R753Q polymorphism and nasopha-
ryngeal S. aureus carriage among healthy infants was recently
found (Vuononvirta et al., 2011). Also, among AD patients, which
are often colonized with the bacteria, 9 out of 78 patients (11.5%)
carried the TLR2 R753Q variant (Ahmad-Nejad et al., 2004). Only
a few studies in mice have addressed the involvement of TLR2, IL-
1R, or MyD88 in nasal carriage of S. aureus. However, inoculation
of S. aureus COL into the nasal cavity of TLR2 and TLR4 knock-
out mice showed that TLR2 was important for the early innate
immune response in the mice, while no signiﬁcant differences
in colony forming units were found between mice 7 days after
inoculation (González-Zorn et al., 2005).
Toll-like receptor signaling can also be inﬂuenced by ligand-
bound glucocorticoid receptor (GR), resulting in reduction in the
expression of pro-inﬂammatory cytokines and up-regulation of
anti-inﬂammatory cytokines (Moynagh, 2003). There aremultiple
isoforms of GR arising from alternative splicing and translational
events of the single gene and various polymorphic variants exist
(Tait et al., 2008). The exon 9β and ER22/23EK polymorphisms
were found to be associated with a 68% decreased and 80%
increased risk of S. aureus nasal carriage, respectively (van den
Akker et al., 2006). The most common glucocorticoid found in
human is cortisol. However, no differences were found in the
long-term cortisol level among carriers and non-carriers of the
bacteria (Manenschijn et al., 2011).
Signaling through NLR
The NLRs are divided into three subfamilies: NALPs, IPAF/NAIP,
and NODs. Most NLRs are expressed in the cytosol. NALP1, -2,
and -3 are central in creating a PAMP-induced caspase-1 activating
complex called the inﬂammasome, which catalyzes the cleavage of
pro-IL-1β and pro-IL-18 into IL-1β and IL-18. The full activa-
tion of inﬂammasomes is tightly regulated and can be divided in
two steps. First, it is primed by the TLR-mediated up-regulation
of expression of pro-IL-1β and other proteins involved in for-
mation of the inﬂammasome. A second signal is needed for the
assembly of the inﬂammasome (Martinon et al., 2009; Gross et al.,
2011). The formation of NALP3 inﬂammasome can be induced
by for instance S. aureus α-hemolysins resulting in IL-1β secretion
(Craven et al., 2009).
NOD2 is expressed in skin and in keratinocytes, and recog-
nize peptidoglycan fragments, e.g., muramyl dipeptide, resulting
in increased expression of β-defensin 2 and various cytokines
(Voss et al., 2006; Siod and Fløisand, 2009). Also, NOD2 has been
suggested to play a role in the activation of some types of inﬂam-
masomes (Martinon et al., 2009). NOD2-deﬁcient mice are highly
susceptible to S. aureus infection, and show highly decreased sur-
vival after injection with living S. aureus (Takeuchi et al., 2000;
Deshmukh et al., 2009). Similarly, NOD2-deﬁcient mice subcu-
taneously injected with S. aureus have reduced ability to clear S.
aureus compared with wild-type mice. The neutrophil recruit-
ment to the skin, as well as serum IgG titers, did not differ between
wild-type and NOD2-deﬁcient mice, suggesting that NOD2 is
dispensable for normal induction of an adaptive immune response
against the bacteria. Instead, NOD2 was required for caspase-
1-released IL-1β which induced IL-6 production and increased
the neutrophil-mediated killing of S. aureus in the skin (Hruz
et al., 2009).
NOD2 mutations have been associated with Crohn’s disease,
and some of the resulting NOD2 proteins were less capable of
responding to the bacterial ligand muramyl dipeptide (Turvey and
Broide, 2010). Neutrophil dysfunction and increased survival of
S. aureus have been reported in these patients (Hruz et al., 2009
and references therein). However, even though the NLR path-
way is of importance in clearing skin infections caused by S.
aureus, it remains elusive whether the pathway is of importance in
determining nasal carriage status.
The complement system
The main function of the complement system is to promote
inﬂammation, opsonization and lysis of microorganisms, and to
remove immune complexes. The complement system consists of
a variety of serum proteins that can be activated by microorgan-
isms by three different routes, the classical pathway, the lectin
pathway, and the alternative pathway. The classical pathway is
activated by C1q binding to antibodies localized on the surface
of the bacteria. The lectin pathway is activated when proteins
such as MBL attach to the carbohydrate on the bacteria thereby
recruiting the MBL-associated serine proteases (MASPs), while
the alternative pathway is activated when C3b covalently binds to
a microbe. The activation of any of these pathways results in acti-
vation of C3, resulting in production of the anaphylatoxinC3a and
the opsonin C3b. The assembly of C5 convertases occurs, result-
ing in the production of anaphylatoxin C5a, as well as C5b and
C6–C9, resulting in the production of the lytic membrane-attack
complex (MAC) which may lyse the microorganism (Kemper and
Atkinson, 2007). The complement system is highly regulated. The
regulators of complement activation (RCA) include various pro-
teins, as for example factor H, which acts to destabilize the C3
convertase or promote the factor I-mediated cleavage of C3b into
iC3b (Lambris et al., 2008). Another important RCA is the serine
protease C1 inhibitor, which regulates both the classical and MBL
pathway by inhibiting C1s/C1r and MASP-1/MASP-2, respectively
(Zeerleder, 2011).
Mannose-binding lectin is a liver-produced circulating plasma
homomultimer complex. Three common polymorphisms are
found in exon 1 (R52C,G54D, and G57E),which interfere with the
oligomerization ability of the polypeptide. The mutations result in
D, B, and C alleles, respectively, while the wild-type allele is named
A. The B and C variants occur in 22–28 and 50–60% of Eurasian
and sub-Saharan African populations, respectively, while the D
variant reaches frequencies of 14% in European populations. In
addition, there are two common polymorphisms also identiﬁed
in the upstream promoter region, which determine serum levels
by regulating protein expression. Therefore, the level of functional
MBL in serum differs among human population due to a high fre-
quency of various polymorphisms in different combinations. Still,
the level is relatively constant within the individual and increases
only two- to threefold upon infectious or inﬂammatory challenge
(Turner, 2003; Ip et al., 2009).
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Mannose-binding lectin is produced at the nasalmucous lining,
and wild-type MBL haplotype A is associated with carriage (van
Belkum et al., 2007), while the nasopharyngeal bacterial coloniza-
tion rates were signiﬁcantly higher in infants with the variant types
B, C, and D of MBL (Vuononvirta et al., 2011). MBL is involved
in opsonophagocytosis, and found to interfere with TLR2/TLR6-
mediated signaling and expression of cytokines in professional
phagocytes (Turner, 2003; Ip et al., 2009), but it is not known
whether the variants of MBL differently inﬂuence these functions.
Another protein that inﬂuences complement activation is the acute
phase protein C-reactive protein (CRP). Single nucleotide poly-
morphisms (SNPs) found in CRP include C1184T (rs1130864),
C2042T (rs1205), and C2911G (rs3093068). The individual SNPs
are not associated with S. aureus carriage, but the CRP haplotype
1184C, 2042C, and 2911C were overrepresented in non-carriers in
a large cohort (Emonts et al., 2008). A challenge in ﬁnding SNPs
associated with carriage is the huge heterogeneous genetic back-
groundbetween individuals. One group investigatednasal carriage
among 154 adult Wayampi Amerindians living in an isolated vil-
lage in the Amazonian forest. The SNPs CRP C2042T and C1184
were found to be signiﬁcantly associated with persistent carriage
in this population (Ruimy et al., 2010).
Various bacteria circumvent the complement activation by var-
ious mechanisms, including recruiting complement regulators to
its surface (Laarman et al., 2010). Recently, S. aureus was found
to recruit the complement regulator factor H, which via factor I
mediated cleavage of C3b, evaded the alternative pathway (Sharp
and Cunnion, 2010). Polymorphisms in factor H may inﬂuence
its expression, or the ability to interact with Sbi or other S. aureus-
derived proteins. So far, only the Y402H variant of factor H has
been tested in epidemiological studies and found not to be associ-
atedwith nasal carriage of S. aureus, but insteadwith occurrence of
boils (Emonts et al., 2008). Another complement regulator is the
serine protease C1 inhibitor. An SNP in position 480, replacing a
valine with a methionine, has been found to be associated with S.
aureus carriage, and theV/V genotype was signiﬁcantly overrepre-
sented in non-carriers (Emonts et al., 2007). Taken together, some
association between certain polymorphisms in complement genes
and nasal carriage of S. aureus have been found, but the molecular
mechanisms behind these remains to be investigated.
Professional phagocytes
The presence of S. aureus results in increased levels of various
AMPs, but also cytokines, chemokines, formylated methionine-
containing proteins and complement which all contribute to
neutrophil rolling, adhesion, diapedesis, and thereby recruitment
of the neutrophils into the skin. The phagocytes engulf the bac-
teria, and kill them by generating reactive oxygen and nitrogen
species, various AMPs, proteinases, and acid hydrolases (Foster,
2005; Miller and Cho, 2011). In addition, neutrophils may try to
defend the host against the bacteria by creating extracellular traps,
which prevent the microbe from spreading and ensure a high local
concentration of antimicrobial agents (Brinkmann et al., 2004).
AIDS patients suffer from impaired phagocytosis of S. aureus
by granulocytes and monocytes. Defects in neutrophil differenti-
ation, migration, or in ability to create a respiratory burst caused
by other diseases might also inﬂuence S. aureus survival (Bouma
et al., 2010; Miller and Cho, 2011). Chronic granulomatous dis-
ease patients, for example, have a defect in either of the proteins
creating NADPH oxidase complex in phagocytes, and have recur-
rent bacterial infectionswhich often are caused by S. aureus (Miller
andCho,2011). The nasal secretion among persistent carriers con-
tained the neutrophil speciﬁc α-defensins 1–3. Light microscope
analysis of Wright-stained nasal ﬂuid conﬁrmed the presence of
neutrophils in donor ﬂuid from carrier and acute rhinitis patients,
but not in ﬂuid from normal donors (Cole et al., 2001). However,
whether these cells had a disturbed ability to clear bacteria was not
addressed.
Carriage of S. aureus and adaptive immunity
Several studies have addressed whether human carriers have ele-
vated levels of antibodies against S. aureus antigens compared to
non-carriers. Many of these studies reveal that carriers have anti-
bodies against various S. aureus antigens (Holtfreter et al., 2006;
Wertheim et al., 2008; Verkaik et al., 2009a; Colque-Navarro et al.,
2010). This may be one of several explanations of why human
nasal carriers of S. aureus have some degree of protection against
fatalities caused by infection (Holtfreter et al., 2006).
One could ask whether the elevated level of antibodies in car-
riers is caused by nasal colonization as such or by minor S. aureus
infections due to scratches in the skin, etc. This question was
recently addressed, and it was found that even though certain non-
enterotoxin superantigens are expressed during nasal colonization,
they did not induce systemic neutralizing antibodies. This suggests
that nasal colonization of intact epithelium is not sufﬁcient for
the induction of a strong serum antibody response (Burian et al.,
2012). Similarly, artiﬁcial colonization of adult volunteers with a
laboratory strain of S. aureus did not elicit signiﬁcant changes in
the existing antibody repertoire (Broker and van Belkum, 2011).
These studies may suggest that elevated levels of antibodies in
carriers are not due to colonization per se.
It has also been questioned whether immunization can pre-
vent colonization. Immunization studies in mice or cotton rats
using IsdA, IsdH, or ClfB showed that immunization protected or
reduced the level of S. aureus colonization (Clarke et al., 2006;
Schaffer et al., 2006). However, young children with placental
transfer of maternal IgG against S. aureus antigens were not pro-
tected against colonization (Verkaik et al., 2009b; Broker and van
Belkum, 2011). More investigations are needed in order to ﬁnally
state whether immunization can be used to prevent colonization.
Th17 and cutaneous S. aureus
Differentiation of CD4+ T cells yields the T helper cells (Th) Th1-,
Th2-, Th17-, and the regulatory T cell (Treg). The signature
cytokines of Th17 are IL-17A and IL-17F, but the cells can also
produce IL-21 and IL-22. The differentiation of CD4+ T cells into
Th17 cells is dependent on cytokines such as IL-1β, IL-6, and IL-23.
The presence of these results in activation of JAK–STAT signaling
pathway, which in turn stimulates the differentiation and produc-
tion of the signature cytokines (Minegishi and Karasuyama, 2009;
Ochs et al., 2009).
Several patients with hyper-IgE syndrome (HIES), or Job’s syn-
drome, have mutations in STAT3 thereby resulting in reduced abil-
ity of T cells to differentiate into Th17 cells. These patients suffer
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from recurrent skin and pulmonary infections, often caused by
S. aureus. AD and HIV patients are also predisposed to S. aureus
cutaneous infections, which may be due to decreased Th17 cell
responses and/or CD4+ cell counts. Similarly, individuals with
autoantibodies against Th17-derived cytokines suffer from Can-
dida infections and S. aureus skin infections. Studies from mice
conﬁrm that IL-17F and IL-17A are involved in host defense
against S. aureus skin infection (Miller and Cho, 2011). How-
ever, whether or how these T cells inﬂuence nasal colonization is
not known.
STRAIN-DEPENDENT INFLUENCE ON HOST CYTOKINE RESPONSE
The genome of S. aureus consists of a conserved core part and
variable parts (Witney et al., 2005; McCarthy and Lindsay, 2010).
The population structures of the nasal S. aureus isolates clearly
illustrate diversity that can be clustered in various groups (Melles
et al., 2004; Sakwinska et al., 2009; Sangvik et al., 2011). It is also
debated whether certain clusters, subclusters, or strains are more
virulent or better colonizers than others (Feil et al., 2003; Melles
et al., 2004; Lindsay et al., 2006; Muthukrishnan et al., 2011).
A few studies have compared the various S. aureus strains
in their ability to inﬂuence the expression of cytokines and
AMPs. Although the molecular mechanisms remain elusive, 10
heat-inactivated clinical isolates varied in their ability to induce
β-defensin 1, β-defensin 2, CAP18, and β-defensin 3 in human pri-
mary keratinocytes (Midorikawa et al., 2003). Also, comparisons
of so-called carrier and non-carrier strains of S. aureus showed
that they varied in their ability to interfere with expression of
TLR2, β-defensin 3, IL-1α, IL-1β, and IL-1Ra in nasal epithe-
lial cell cultures (Quinn and Cole, 2007; Quinn et al., 2009). The
strains also varied in their ability to form bioﬁlms, and in sensi-
tivity to IL-1α-mediated growth inhibition (Quinn et al., 2009).
Studies in human umbilical vein endothelial cells have shown that
the various S. aureus strains are equally invasive,while theydiffered
greatly in their ability to induce inﬂammation perhaps depending
on presence/absence of the agr (Grundmeier et al., 2010). Another
putative mechanism affecting inﬂuence on cytokine expression
is presence or absence of β-hemolysin in the S. aureus strains,
as β-hemolysin is shown to inﬂuence endothelial IL-8 expression
(Tajima et al., 2007, 2009). All these studies indicate that the cel-
lular response may vary depending on the S. aureus strain, which
may inﬂuence the success for colonization of a particular strain.
CONCLUSION
Persistent nasal carriage of S. aureus is a complicated interplay
between host and bacteria. In order to persistently colonize a
human host, S. aureus must adhere to the skin and avoid being
eliminated due to the human immune response. Presence or
expression of appropriate MSCRAMMs and immune evasion
molecules are needed for successful colonization. Moreover, the
microﬂora in the nasal cavity inﬂuences the ability of S. aureus
to colonize. The adhesion involves correct combinations and
expression levels of bacterial adhesins and corresponding host
interaction partners. Persistent carriers may have reduced expres-
sion levels of other antimicrobial molecules and/or a less efﬁcient
combination of these on the skin. Indeed, lower expression of β-
defensin 3 is found to be associated with carriage. Another option
is that the persistent carriers have polymorphic variants of the
antimicrobial molecules, or enzymes involved in making these,
resulting in less efﬁcient molecules or reduced amounts of the
antimicrobial molecules, respectively.
Nasal secretions among carriers reveal presence of certain
AMPs including the neutrophil-derived HNPs. This may indicate
S. aureus-mediated activation of the immune system, but with-
out eliminating the bacteria. The molecular mechanisms behind
this phenomenon remain to be investigated. Keratinocytes and
immune cells also express various PRRs. Activation of these may
result in productionof antimicrobialmolecules and/or production
of various cytokines. Polymorphic variants of PRRs may interfere
with their ability to detect PAMPs and thereby the host response.
Similarly, as activation of PRR may result in activation in signal-
ing pathways resulting in an altered gene response, polymorphic
variants in any of these molecules may interfere with the ability of
the host to respond to the presence of the bacteria.
Future studies will provide further knowledge regarding host
and bacterial determinants involved in colonization. S. aureus col-
onization is an important risk factor for infection. By identifying
determinants involved in colonization, putative molecules inhibit-
ing colonizationmaybeproduced,which againwill lead to reduced
risk of infection by the endogenous S. aureus.
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